Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 205 articles:
HTML format
Text format



Single Articles


    January 2016
  1. HEISE R, Amann PM, Ensslen S, Marquardt Y, et al
    Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
    PLoS One. 2016;11:e0146325.
    PubMed     Text format     Abstract available


  2. MEHTA K, Appleman L, Wang H, Tarhini AA, et al
    Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients.
    PLoS One. 2016;11:e0147153.
    PubMed     Text format     Abstract available


  3. SHEEN YS, Liao YH, Lin MH, Chiu HC, et al
    Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
    PLoS One. 2016;11:e0147431.
    PubMed     Text format     Abstract available


  4. LIU J, Shen B, Shi M, Cai J, et al
    Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study.
    PLoS One. 2016;11:e0147056.
    PubMed     Text format     Abstract available


  5. VENKATESAN N, Kanwar J, Deepa PR, Khetan V, et al
    Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    PLoS One. 2016;11:e0146128.
    PubMed     Text format     Abstract available


  6. TIWARY S, Xu L
    FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells.
    PLoS One. 2016;11:e0147638.
    PubMed     Text format     Abstract available


  7. FAN L, Li H, Niu Y, Chen Q, et al
    Characterization and Inducing Melanoma Cell Apoptosis Activity of Mannosylerythritol Lipids-A Produced from Pseudozyma aphidis.
    PLoS One. 2016;11:e0148198.
    PubMed     Text format     Abstract available


  8. PICH C, Teiti I, Sarrabayrouse G, Gallardo F, et al
    Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity.
    PLoS One. 2016;11:e0148095.
    PubMed     Text format     Abstract available


  9. DUPRAT JP, Brechtbulh ER, Costa de Sa B, Enokihara M, et al
    Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.
    PLoS One. 2016;11:e0148160.
    PubMed     Text format     Abstract available


  10. EIKE LM, Mauseth B, Camilio KA, Rekdal O, et al
    The Cytolytic Amphipathic beta(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.
    PLoS One. 2016;11:e0148980.
    PubMed     Text format     Abstract available


  11. OBA J, Nakahara T, Hashimoto-Hachiya A, Liu M, et al
    CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis.
    PLoS One. 2016;11:e0149285.
    PubMed     Text format     Abstract available


  12. KRYZA D, Debordeaux F, Azema L, Hassan A, et al
    Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.
    PLoS One. 2016;11:e0149387.
    PubMed     Text format     Abstract available


  13. HURABIELLE C, Pillebout E, Stehle T, Pages C, et al
    Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.
    PLoS One. 2016;11:e0149873.
    PubMed     Text format     Abstract available


  14. STASIAK M, Boncela J, Perreau C, Karamanou K, et al
    Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.
    PLoS One. 2016;11:e0150226.
    PubMed     Text format     Abstract available


  15. TOIA F, Buccheri S, Anfosso A, Moschella F, et al
    Skewed Differentiation of Circulating Vgamma9Vdelta2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.
    PLoS One. 2016;11:e0149570.
    PubMed     Text format     Abstract available


  16. NEWMAN JA, Cooper CD, Roos AK, Aitkenhead H, et al
    Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.
    PLoS One. 2016;11:e0148762.
    PubMed     Text format     Abstract available


  17. KOSZALKA P, Golunska M, Urban A, Stasilojc G, et al
    Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
    PLoS One. 2016;11:e0151420.
    PubMed     Text format     Abstract available


  18. JOHANSEN P, Andersen JD, Madsen LN, Ullum H, et al
    Pigmentary Markers in Danes - Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.
    PLoS One. 2016;11:e0150381.
    PubMed     Text format     Abstract available


  19. KABILOVA TO, Sen'kova AV, Nikolin VP, Popova NA, et al
    Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice.
    PLoS One. 2016;11:e0150751.
    PubMed     Text format     Abstract available


  20. PAPPALARDO F, Russo G, Candido S, Pennisi M, et al
    Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer.
    PLoS One. 2016;11:e0152104.
    PubMed     Text format     Abstract available


  21. KASAI S, Arakawa N, Okubo A, Shigeeda W, et al
    NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
    PLoS One. 2016;11:e0153181.
    PubMed     Text format     Abstract available


  22. GRECKA E, Statkiewicz M, Gorska A, Biernacka M, et al
    Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
    PLoS One. 2016;11:e0153633.
    PubMed     Text format     Abstract available


  23. SATO S, Murakami A, Kuwajima A, Takehara K, et al
    Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
    PLoS One. 2016;11:e0154285.
    PubMed     Text format     Abstract available


  24. HARLE A, Salleron J, Franczak C, Dubois C, et al
    Detection of BRAF Mutations Using a Fully Automated Platform and Comparison with High Resolution Melting, Real-Time Allele Specific Amplification, Immunohistochemistry and Next Generation Sequencing Assays, for Patients with Metastatic Melanoma.
    PLoS One. 2016;11:e0153576.
    PubMed     Text format     Abstract available


  25. BLOKZIJL A, Chen LE, Gustafsdottir SM, Vuu J, et al
    Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay.
    PLoS One. 2016;11:e0154214.
    PubMed     Text format     Abstract available


    January 2015
  26. MARTIN DEL CAMPO SE, Latchana N, Levine KM, Grignol VP, et al
    MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor.
    PLoS One. 2015;10:e0115919.
    PubMed     Text format     Abstract available


  27. BEUTEL ME, Fischbeck S, Binder H, Blettner M, et al
    Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study.
    PLoS One. 2015;10:e0116440.
    PubMed     Text format     Abstract available


  28. RIBERO S, Glass D, Aviv A, Spector TD, et al
    Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility.
    PLoS One. 2015;10:e0116863.
    PubMed     Text format     Abstract available


  29. MORETTI D, Del Bello B, Allavena G, Corti A, et al
    Calpain-3 Impairs Cell Proliferation and Stimulates Oxidative Stress-Mediated Cell Death in Melanoma Cells.
    PLoS One. 2015;10:e0117258.
    PubMed     Text format     Abstract available


  30. GARAY T, Kenessey I, Molnar E, Juhasz E, et al
    Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells.
    PLoS One. 2015;10:e0117021.
    PubMed     Text format     Abstract available


  31. PERETZ Y, Wu H, Patel S, Bellacosa A, et al
    Inhibitor of DNA Binding 4 (ID4) Is Highly Expressed in Human Melanoma Tissues and May Function to Restrict Normal Differentiation of Melanoma Cells.
    PLoS One. 2015;10:e0116839.
    PubMed     Text format     Abstract available


  32. KATOH D, Nishizuka M, Osada S, Imagawa M, et al
    Fad104, a Positive Regulator of Adipocyte Differentiation, Suppresses Invasion and Metastasis of Melanoma Cells by Inhibition of STAT3 Activity.
    PLoS One. 2015;10:e0117197.
    PubMed     Text format     Abstract available


  33. CHIEN CH, Lee MJ, Liou HC, Liou HH, et al
    Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice.
    PLoS One. 2015;10:e0115827.
    PubMed     Text format     Abstract available


  34. FAIAO-FLORES F, Quincoces Suarez JA, Fruet AC, Maria-Engler SS, et al
    Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression.
    PLoS One. 2015;10:e0118702.
    PubMed     Text format     Abstract available



  35. Correction: Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation.
    PLoS One. 2015;10:e0118728.
    PubMed     Text format     Abstract available


  36. VERSLUIS M, de Lange MJ, van Pelt SI, Ruivenkamp CA, et al
    Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma.
    PLoS One. 2015;10:e0116371.
    PubMed     Text format     Abstract available


  37. ZIMMER L, Vaubel J, Mohr P, Hauschild A, et al
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naive Patients with Metastatic Uveal Melanoma.
    PLoS One. 2015;10:e0118564.
    PubMed     Text format     Abstract available


  38. BRONCHALO-VICENTE L, Rodriguez-Del Rio E, Freire J, Calderon-Gonzalez R, et al
    A Novel Therapy for Melanoma Developed in Mice: Transformation of Melanoma into Dendritic Cells with Listeria monocytogenes.
    PLoS One. 2015;10:e0117923.
    PubMed     Text format     Abstract available


  39. PFARR K, Danciu C, Arlt O, Neske C, et al
    Simultaneous and dose dependent melanoma cytotoxic and immune stimulatory activity of betulin.
    PLoS One. 2015;10:e0118802.
    PubMed     Text format     Abstract available


  40. TAYLOR NJ, Busam KJ, From L, Groben PA, et al
    Inherited Variation at MC1R and Histological Characteristics of Primary Melanoma.
    PLoS One. 2015;10:e0119920.
    PubMed     Text format     Abstract available


  41. MOURAH S, Denis MG, Narducci FE, Solassol J, et al
    Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas(R) 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (INCa) Platforms in a Real-Life Setting.
    PLoS One. 2015;10:e0120232.
    PubMed     Text format     Abstract available


  42. KOCARNIK JM, Park SL, Han J, Dumitrescu L, et al
    Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    PLoS One. 2015;10:e0120491.
    PubMed     Text format     Abstract available


  43. REN S, Chai L, Wang C, Li C, et al
    Human malignant melanoma-derived progestagen-associated endometrial protein immunosuppresses T lymphocytes in vitro.
    PLoS One. 2015;10:e0119038.
    PubMed     Text format     Abstract available


  44. VALPIONE S, Moser JC, Parrozzani R, Bazzi M, et al
    Development and external validation of a prognostic nomogram for metastatic uveal melanoma.
    PLoS One. 2015;10:e0120181.
    PubMed     Text format     Abstract available


  45. GENG P, Liao Y, Ruan Z, Liang H, et al
    Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism.
    PLoS One. 2015;10:e0118112.
    PubMed     Text format     Abstract available


  46. BAI J, Lei Y, An GL, He L, et al
    Down-Regulation of Deacetylase HDAC6 Inhibits the Melanoma Cell Line A375.S2 Growth through ROS-Dependent Mitochondrial Pathway.
    PLoS One. 2015;10:e0121247.
    PubMed     Text format     Abstract available


  47. HAN D, Han G, Zhao X, Rao NG, et al
    Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma.
    PLoS One. 2015;10:e0119716.
    PubMed     Text format     Abstract available


  48. XU MJ, Cooke M, Steinmetz D, Karakousis G, et al
    A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.
    PLoS One. 2015;10:e0123376.
    PubMed     Text format     Abstract available


  49. WADT KA, Aoude LG, Krogh L, Sunde L, et al
    Molecular characterization of melanoma cases in denmark suspected of genetic predisposition.
    PLoS One. 2015;10:e0122662.
    PubMed     Text format     Abstract available


  50. JENKINS MH, Brinckerhoff CE, Mullins DW
    CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity.
    PLoS One. 2015;10:e0121140.
    PubMed     Text format     Abstract available


  51. KREISEDER B, Holper-Schichl YM, Muellauer B, Jacobi N, et al
    Alpha-Catulin Contributes to Drug-Resistance of Melanoma by Activating NF-kappaB and AP-1.
    PLoS One. 2015;10:e0119402.
    PubMed     Text format     Abstract available



  52. Correction: Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation.
    PLoS One. 2015;10:e0122943.
    PubMed     Text format     Abstract available


  53. ARTS N, Cane S, Hennequart M, Lamy J, et al
    microRNA-155, Induced by Interleukin-1ss, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells.
    PLoS One. 2015;10:e0122517.
    PubMed     Text format     Abstract available


  54. GOWRISHANKAR K, Gunatilake D, Gallagher SJ, Tiffen J, et al
    Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-kappaB.
    PLoS One. 2015;10:e0123410.
    PubMed     Text format     Abstract available


  55. BARTLETT D, Boyle GM, Ziman M, Medic S, et al
    Mechanisms Contributing to Differential Regulation of PAX3 Downstream Target Genes in Normal Human Epidermal Melanocytes versus Melanoma Cells.
    PLoS One. 2015;10:e0124154.
    PubMed     Text format     Abstract available


  56. RAUSCH MP, Hastings KT
    An Exhaustion-Like Phenotype Constrains the Activity of CD4+ T Cells Specific for a Self and Melanoma Antigen.
    PLoS One. 2015;10:e0123332.
    PubMed     Text format     Abstract available


  57. MOLOGNONI F, de Melo FH, da Silva CT, Jasiulionis MG, et al
    Correction: Ras and Rac1, Frequently Mutated in Melanomas, Are Activated by Superoxide Anion, Modulate Dnmt1 Level and Are Causally Related to Melanocyte Malignant Transformation.
    PLoS One. 2015;10:e0124983.
    PubMed     Text format     Abstract available


  58. WELINDER C, Pawlowski K, Sugihara Y, Yakovleva M, et al
    A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues.
    PLoS One. 2015;10:e0123661.
    PubMed     Text format     Abstract available


  59. MARQUEZ-RODAS I, Martin Gonzalez M, Nagore E, Gomez-Fernandez C, et al
    Frequency and Characteristics of Familial Melanoma in Spain: The FAM-GEM-1 Study.
    PLoS One. 2015;10:e0124239.
    PubMed     Text format     Abstract available


  60. WANG Y, Lv J, Cheng Y, Du J, et al
    Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent.
    PLoS One. 2015;10:e0124812.
    PubMed     Text format     Abstract available


  61. CURL P, Vujic I, van 't Veer LJ, Ortiz-Urda S, et al
    Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma.
    PLoS One. 2015;10:e0126988.
    PubMed     Text format     Abstract available


  62. ATKINSON JM, Rank KB, Zeng Y, Capen A, et al
    Activating the Wnt/beta-Catenin Pathway for the Treatment of Melanoma - Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
    PLoS One. 2015;10:e0125028.
    PubMed     Text format     Abstract available


  63. ROSSI AH, Farias A, Fernandez JE, Bonomi HR, et al
    Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.
    PLoS One. 2015;10:e0126827.
    PubMed     Text format     Abstract available


  64. WYATT C, Lucas RM, Hurst C, Kimlin MG, et al
    Vitamin d deficiency at melanoma diagnosis is associated with higher breslow thickness.
    PLoS One. 2015;10:e0126394.
    PubMed     Text format     Abstract available


  65. SUN L, Bian G, Meng Z, Dang G, et al
    MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.
    PLoS One. 2015;10:e0124428.
    PubMed     Text format     Abstract available


  66. KINIWA Y, Li J, Wang M, Sun C, et al
    Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4+ Th1 Cells.
    PLoS One. 2015;10:e0124094.
    PubMed     Text format     Abstract available


  67. MORIARTY JP, Borah BJ, Foote RL, Pulido JS, et al
    Cost-effectiveness of proton beam therapy for intraocular melanoma.
    PLoS One. 2015;10:e0127814.
    PubMed     Text format     Abstract available


  68. RADAELLI E, Hermans E, Omodho L, Francis A, et al
    Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.
    PLoS One. 2015;10:e0124974.
    PubMed     Text format     Abstract available


  69. HARTMAN ML, Talar B, Gajos-Michniewicz A, Czyz M, et al
    MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.
    PLoS One. 2015;10:e0128796.
    PubMed     Text format     Abstract available


  70. VAMAN V S A, Poppe H, Houben R, Grunewald TG, et al
    LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.
    PLoS One. 2015;10:e0129219.
    PubMed     Text format     Abstract available


  71. PAOLONI M, Mazcko C, Selting K, Lana S, et al
    Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.
    PLoS One. 2015;10:e0129954.
    PubMed     Text format     Abstract available


  72. CARBOGNIN L, Pilotto S, Milella M, Vaccaro V, et al
    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
    PLoS One. 2015;10:e0130142.
    PubMed     Text format     Abstract available


  73. FUKUDA K, Sugihara E, Ohta S, Izuhara K, et al
    Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.
    PLoS One. 2015;10:e0129704.
    PubMed     Text format     Abstract available


  74. SHEN J, Gopalakrishnan V, Lee JE, Fang S, et al
    Mitochondrial DNA Copy Number in Peripheral Blood and Melanoma Risk.
    PLoS One. 2015;10:e0131649.
    PubMed     Text format     Abstract available


  75. RAFIQ RA, Quadri A, Nazir LA, Peerzada K, et al
    A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3', 4', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells.
    PLoS One. 2015;10:e0131253.
    PubMed     Text format     Abstract available


  76. CATTANEO L, Cicconi R, Mignogna G, Giorgi A, et al
    Anti-Proliferative Effect of Rosmarinus officinalis L. Extract on Human Melanoma A375 Cells.
    PLoS One. 2015;10:e0132439.
    PubMed     Text format     Abstract available


  77. SHAO Z, Bao Q, Jiang F, Qian H, et al
    VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo.
    PLoS One. 2015;10:e0132655.
    PubMed     Text format     Abstract available


  78. TARHINI AA, Lin Y, Zahoor H, Shuai Y, et al
    Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-alpha but Not Observation in Intermediate Risk Melanoma Patients.
    PLoS One. 2015;10:e0132745.
    PubMed     Text format     Abstract available


  79. MARZAGALLI M, Casati L, Moretti RM, Montagnani Marelli M, et al
    Estrogen Receptor beta Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.
    PLoS One. 2015;10:e0134396.
    PubMed     Text format     Abstract available


  80. MESSAOUDENE M, Perier A, Fregni G, Neves E, et al
    Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
    PLoS One. 2015;10:e0133363.
    PubMed     Text format     Abstract available


  81. SALVATIERRA E, Alvarez MJ, Leishman CC, Rivas Baquero E, et al
    SPARC Controls Melanoma Cell Plasticity through Rac1.
    PLoS One. 2015;10:e0134714.
    PubMed     Text format     Abstract available


  82. CLAWSON GA, Matters GL, Xin P, Imamura-Kawasawa Y, et al
    Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients.
    PLoS One. 2015;10:e0134320.
    PubMed     Text format     Abstract available


  83. BHANDARU M, Martinka M, McElwee KJ, Rotte A, et al
    Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
    PLoS One. 2015;10:e0134678.
    PubMed     Text format     Abstract available


  84. CRABB JW, Hu B, Crabb JS, Triozzi P, et al
    iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
    PLoS One. 2015;10:e0135543.
    PubMed     Text format     Abstract available


  85. FISCHBECK S, Imruck BH, Blettner M, Weyer V, et al
    Psychosocial Care Needs of Melanoma Survivors: Are They Being Met?
    PLoS One. 2015;10:e0132754.
    PubMed     Text format     Abstract available


  86. HALDER B, Singh S, Thakur SS
    Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
    PLoS One. 2015;10:e0137498.
    PubMed     Text format     Abstract available


  87. MARKOV OV, Mironova NL, Sennikov SV, Vlassov VV, et al
    Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    PLoS One. 2015;10:e0136911.
    PubMed     Text format     Abstract available


  88. DE LANGE MJ, Razzaq L, Versluis M, Verlinde S, et al
    Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.
    PLoS One. 2015;10:e0138002.
    PubMed     Text format     Abstract available


  89. MANGANA J, Cheng PF, Schindler K, Weide B, et al
    Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
    PLoS One. 2015;10:e0139438.
    PubMed     Text format     Abstract available


  90. CAPALDO BJ, Roller D, Axelrod MJ, Koeppel AF, et al
    Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.
    PLoS One. 2015;10:e0138210.
    PubMed     Text format     Abstract available


  91. SPIESBERGER K, Paulfranz F, Egger A, Reiser J, et al
    Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.
    PLoS One. 2015;10:e0140471.
    PubMed     Text format     Abstract available


  92. FRIEDMAN AA, Amzallag A, Pruteanu-Malinici I, Baniya S, et al
    Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
    PLoS One. 2015;10:e0140310.
    PubMed     Text format     Abstract available


  93. GALVAN DL, O'Neil RT, Foster AE, Huye L, et al
    Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.
    PLoS One. 2015;10:e0140744.
    PubMed     Text format     Abstract available


  94. CARON JM, Caron JM
    Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells.
    PLoS One. 2015;10:e0141565.
    PubMed     Text format     Abstract available


  95. HALDER B, Singh S, Thakur SS
    Correction: Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells.
    PLoS One. 2015;10:e0141053.
    PubMed     Text format     Abstract available


  96. SHAO H, Kong R, Ferrari ML, Radtke F, et al
    Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion.
    PLoS One. 2015;10:e0142815.
    PubMed     Text format     Abstract available


  97. STADLER J, Eder J, Pratscher B, Brandt S, et al
    SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.
    PLoS One. 2015;10:e0142273.
    PubMed     Text format     Abstract available


  98. KAUSHIK A, Bhatia Y, Ali S, Gupta D, et al
    Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma.
    PLoS One. 2015;10:e0142443.
    PubMed     Text format     Abstract available


  99. PYATNITSKIY M, Karpov D, Poverennaya E, Lisitsa A, et al
    Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
    PLoS One. 2015;10:e0142819.
    PubMed     Text format     Abstract available


  100. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  101. LIU YM, Li Y, Wei WB, Xu X, et al
    Clinical Characteristics of 582 Patients with Uveal Melanoma in China.
    PLoS One. 2015;10:e0144562.
    PubMed     Text format     Abstract available


  102. MIYASHITA A, Fukushima S, Nakahara S, Yamashita J, et al
    Investigation of FOXM1 as a Potential New Target for Melanoma.
    PLoS One. 2015;10:e0144241.
    PubMed     Text format     Abstract available


  103. LARKIN J, Hatswell AJ, Nathan P, Lebmeier M, et al
    The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.
    PLoS One. 2015;10:e0145524.
    PubMed     Text format     Abstract available


  104. SCHARTL M, Shen Y, Maurus K, Walter R, et al
    Whole Body Melanoma Transcriptome Response in Medaka.
    PLoS One. 2015;10:e0143057.
    PubMed     Text format     Abstract available


  105. UZANA R, Eisenberg G, Merims S, Frankenburg S, et al
    Human T cell crosstalk is induced by tumor membrane transfer.
    PLoS One. 2015;10:e0118244.
    PubMed     Text format     Abstract available


  106. LHOUMEAU AC, Martinez S, Boher JM, Monges G, et al
    Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
    PLoS One. 2015;10:e0123768.
    PubMed     Text format     Abstract available


  107. MARTEL G, Hawel J, Rekman J, Croome KP, et al
    Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study.
    PLoS One. 2015;10:e0120569.
    PubMed     Text format     Abstract available


  108. CHRISTOPHE C, Muller S, Rodrigues M, Petit AE, et al
    A biased competition theory of cytotoxic T lymphocyte interaction with tumor nodules.
    PLoS One. 2015;10:e0120053.
    PubMed     Text format     Abstract available


  109. KRIZBAI IA, Gasparics A, Nagyoszi P, Fazakas C, et al
    Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation.
    PLoS One. 2015;10:e0123845.
    PubMed     Text format     Abstract available


    January 2014
  110. TARHINI AA, Edington H, Butterfield LH, Lin Y, et al
    Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.
    PLoS One. 2014;9:e87705.
    PubMed     Text format     Abstract available


  111. SORENSEN MR, Pedersen SR, Lindkvist A, Christensen JP, et al
    Quantification of B16 Melanoma Cells in Lungs Using Triplex Q-PCR - A New Approach to Evaluate Melanoma Cell Metastasis and Tumor Control.
    PLoS One. 2014;9:e87831.
    PubMed     Text format     Abstract available


  112. MIRKINA I, Hadzijusufovic E, Krepler C, Mikula M, et al
    Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R.
    PLoS One. 2014;9:e84417.
    PubMed     Text format     Abstract available


  113. FEDERICI C, Petrucci F, Caimi S, Cesolini A, et al
    Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin.
    PLoS One. 2014;9:e88193.
    PubMed     Text format     Abstract available


  114. CHANG L, Pei J, Li C, Zhang P, et al
    Incidence and Metastasis of Cutaneous Malignant Melanoma with Respect to ABO Blood Groups: A Case-Controlled Study in Northeast of China.
    PLoS One. 2014;9:e88096.
    PubMed     Text format     Abstract available


  115. PEITSCH WK, Doerflinger Y, Fischer-Colbrie R, Huck V, et al
    Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells.
    PLoS One. 2014;9:e89491.
    PubMed     Text format     Abstract available


  116. CHATTOPADHYAY C, Grimm EA, Woodman SE
    Simultaneous Inhibition of the HGF/MET and Erk1/2 Pathways Affect Uveal Melanoma Cell Growth and Migration.
    PLoS One. 2014;9:e83957.
    PubMed     Text format     Abstract available


  117. SZTILLER-SIKORSKA M, Koprowska K, Majchrzak K, Hartman M, et al
    Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells.
    PLoS One. 2014;9:e90783.
    PubMed     Text format     Abstract available


  118. MCMURPHY T, Xiao R, Magee D, Slater A, et al
    The anti-tumor activity of a neutralizing nanobody targeting leptin receptor in a mouse model of melanoma.
    PLoS One. 2014;9:e89895.
    PubMed     Text format     Abstract available


  119. UMEMURA M, Baljinnyam E, Feske S, De Lorenzo MS, et al
    Store-Operated Ca(2) (+) Entry (SOCE) Regulates Melanoma Proliferation and Cell Migration.
    PLoS One. 2014;9:e89292.
    PubMed     Text format     Abstract available


  120. MECKBACH D, Keim U, Richter S, Leiter U, et al
    BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy.
    PLoS One. 2014;9:e89218.
    PubMed     Text format     Abstract available


  121. GUNGOR B, Gombos I, Crul T, Ayaydin F, et al
    Rac1 Participates in Thermally Induced Alterations of the Cytoskeleton, Cell Morphology and Lipid Rafts, and Regulates the Expression of Heat Shock Proteins in B16F10 Melanoma Cells.
    PLoS One. 2014;9:e89136.
    PubMed     Text format     Abstract available


  122. MORRIS JC, Tan AR, Olencki TE, Shapiro GI, et al
    Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFbeta) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma.
    PLoS One. 2014;9:e90353.
    PubMed     Text format     Abstract available


  123. HALDER K, Banerjee S, Bose A, Majumder S, et al
    Overexpressed PKCdelta Downregulates the Expression of PKCalpha in B16F10 Melanoma: Induction of Apoptosis by PKCdelta via Ceramide Generation.
    PLoS One. 2014;9:e91656.
    PubMed     Text format     Abstract available


  124. QI CL, Wei B, Ye J, Yang Y, et al
    P-selectin-mediated platelet adhesion promotes the metastasis of murine melanoma cells.
    PLoS One. 2014;9:e91320.
    PubMed     Text format     Abstract available


  125. KIM HS, Kim TJ, Yoo YM
    Melatonin Combined with Endoplasmic Reticulum Stress Induces Cell Death via the PI3K/Akt/mTOR Pathway in B16F10 Melanoma Cells.
    PLoS One. 2014;9:e92627.
    PubMed     Text format     Abstract available


  126. TALONI A, Alemi AA, Ciusani E, Sethna JP, et al
    Mechanical properties of growing melanocytic nevi and the progression to melanoma.
    PLoS One. 2014;9:e94229.
    PubMed     Text format     Abstract available


  127. FARZAN SF, Karagas MR, Christensen BC, Li Z, et al
    RNASEL and MIR146A SNP-SNP Interaction as a Susceptibility Factor for Non-Melanoma Skin Cancer.
    PLoS One. 2014;9:e93602.
    PubMed     Text format     Abstract available


  128. OLSEN CM, Knight LL, Green AC
    Risk of Melanoma in People with HIV/AIDS in the Pre- and Post-HAART Eras: A Systematic Review and Meta-Analysis of Cohort Studies.
    PLoS One. 2014;9:e95096.
    PubMed     Text format     Abstract available


  129. CHIEN AJ, Haydu LE, Biechele TL, Kulikauskas RM, et al
    Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/beta-Catenin Signaling.
    PLoS One. 2014;9:e94748.
    PubMed     Text format     Abstract available


  130. HARTMAN ML, Talar B, Noman MZ, Gajos-Michniewicz A, et al
    Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype.
    PLoS One. 2014;9:e95157.
    PubMed     Text format     Abstract available


  131. LI R, Zhang L, Jia L, Duan Y, et al
    MicroRNA-143 Targets Syndecan-1 to Repress Cell Growth in Melanoma.
    PLoS One. 2014;9:e94855.
    PubMed     Text format     Abstract available


  132. FUJITA Y, Koinuma S, De Velasco MA, Bolz J, et al
    Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.
    PLoS One. 2014;9:e94772.
    PubMed     Text format     Abstract available


  133. MACAULAY EC, Roberts HE, Cheng X, Jeffs AR, et al
    Retrotransposon hypomethylation in melanoma and expression of a placenta-specific gene.
    PLoS One. 2014;9:e95840.
    PubMed     Text format     Abstract available


  134. AGUILAR-GUZMAN L, Lobos-Gonzalez L, Rosas C, Vallejos G, et al
    Human Survivin and Trypanosoma cruzi Calreticulin Act in Synergy against a Murine Melanoma In Vivo.
    PLoS One. 2014;9:e95457.
    PubMed     Text format     Abstract available


  135. SALAMON J, Hoffmann T, Elies E, Peldschus K, et al
    Antibody Directed against Human YKL-40 Increases Tumor Volume in a Human Melanoma Xenograft Model in Scid Mice.
    PLoS One. 2014;9:e95822.
    PubMed     Text format     Abstract available


  136. PENG HY, Lin CC, Wang HY, Shih Y, et al
    The Melanogenesis Alteration Effects of Achillea millefolium L. Essential Oil and Linalyl Acetate: Involvement of Oxidative Stress and the JNK and ERK Signaling Pathways in Melanoma Cells.
    PLoS One. 2014;9:e95186.
    PubMed     Text format     Abstract available


  137. ARROYO-BERDUGO Y, Alonso S, Ribas G, Ibarrola-Villava M, et al
    Involvement of ANXA5 and ILKAP in Susceptibility to Malignant Melanoma.
    PLoS One. 2014;9:e95522.
    PubMed     Text format     Abstract available


  138. PEREIRA FV, Ferreira-Guimaraes CA, Paschoalin T, Scutti JA, et al
    A Natural Bacterial-Derived Product, the Metalloprotease Arazyme, Inhibits Metastatic Murine Melanoma by Inducing MMP-8 Cross-Reactive Antibodies.
    PLoS One. 2014;9:e96141.
    PubMed     Text format     Abstract available


  139. FOFARIA NM, Kim SH, Srivastava SK
    Piperine Causes G1 Phase Cell Cycle Arrest and Apoptosis in Melanoma Cells through Checkpoint Kinase-1 Activation.
    PLoS One. 2014;9:e94298.
    PubMed     Text format     Abstract available


  140. OBRADOR E, Valles SL, Benlloch M, Sirerol JA, et al
    Glucocorticoid Receptor Knockdown Decreases the Antioxidant Protection of B16 Melanoma Cells: An Endocrine System-Related Mechanism that Compromises Metastatic Cell Resistance to Vascular Endothelium-Induced Tumor Cytotoxicity.
    PLoS One. 2014;9:e96466.
    PubMed     Text format     Abstract available


  141. REDMER T, Welte Y, Behrens D, Fichtner I, et al
    The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells.
    PLoS One. 2014;9:e92596.
    PubMed     Text format     Abstract available


  142. ECSEDI S, Hernandez-Vargas H, Lima SC, Vizkeleti L, et al
    DNA methylation characteristics of primary melanomas with distinct biological behaviour.
    PLoS One. 2014;9:e96612.
    PubMed     Text format     Abstract available


  143. NASPI A, Panasiti V, Abbate F, Roberti V, et al
    Insulin-Like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression In Vitro and In Vivo.
    PLoS One. 2014;9:e98641.
    PubMed     Text format     Abstract available


  144. RIBEIRO-PEREIRA C, Moraes JA, Souza Mde J, Laurindo FR, et al
    Redox Modulation of FAK Controls Melanoma Survival - Role of NOX4.
    PLoS One. 2014;9:e99481.
    PubMed     Text format     Abstract available


  145. REES JR, Zens MS, Gui J, Celaya MO, et al
    Non melanoma skin cancer and subsequent cancer risk.
    PLoS One. 2014;9:e99674.
    PubMed     Text format     Abstract available


  146. CHEN J, Li L, Su J, Li B, et al
    Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin.
    PLoS One. 2014;9:e101277.
    PubMed     Text format     Abstract available


  147. LI R, Zhang L, Jia L, Duan Y, et al
    Long Non-Coding RNA BANCR Promotes Proliferation in Malignant Melanoma by Regulating MAPK Pathway Activation.
    PLoS One. 2014;9:e100893.
    PubMed     Text format     Abstract available


  148. AOUDE LG, Xu M, Zhao ZZ, Kovacs M, et al
    Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene.
    PLoS One. 2014;9:e100683.
    PubMed     Text format     Abstract available


  149. PENN LA, Qian M, Zhang E, Ng E, et al
    Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance.
    PLoS One. 2014;9:e101507.
    PubMed     Text format     Abstract available



  150. Correction: Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy.
    PLoS One. 2014;9:e101732.
    PubMed     Text format     Abstract available


  151. YAMAMOTO S, Hotta MM, Okochi M, Honda H, et al
    Effect of Vascular Formed Endothelial Cell Network on the Invasive Capacity of Melanoma Using the In Vitro 3D Co-Culture Patterning Model.
    PLoS One. 2014;9:e103502.
    PubMed     Text format     Abstract available


  152. YANG J, Bill MA, Young GS, La Perle K, et al
    Novel Small Molecule XPO1/CRM1 Inhibitors Induce Nuclear Accumulation of TP53, Phosphorylated MAPK and Apoptosis in Human Melanoma Cells.
    PLoS One. 2014;9:e102983.
    PubMed     Text format     Abstract available


  153. ZHANG YP, Chu RX, Liu H
    Vitamin a intake and risk of melanoma: a meta-analysis.
    PLoS One. 2014;9:e102527.
    PubMed     Text format     Abstract available


  154. KLEEMANN B, Loos B, Scriba TJ, Lang D, et al
    St John's Wort (Hypericum perforatum L.) Photomedicine: Hypericin-Photodynamic Therapy Induces Metastatic Melanoma Cell Death.
    PLoS One. 2014;9:e103762.
    PubMed     Text format     Abstract available


  155. VILELA FM, Syed DN, Chamcheu JC, Calvo-Castro LA, et al
    Biotransformed Soybean Extract (BSE) Inhibits Melanoma Cell Growth and Viability In Vitro: Involvement of Nuclear Factor-Kappa B Signaling.
    PLoS One. 2014;9:e103248.
    PubMed     Text format     Abstract available


  156. LOPEZ S, Garcia O, Yurrebaso I, Flores C, et al
    The Interplay between Natural Selection and Susceptibility to Melanoma on Allele 374F of SLC45A2 Gene in a South European Population.
    PLoS One. 2014;9:e104367.
    PubMed     Text format     Abstract available



  157. Correction: The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells.
    PLoS One. 2014;9:e105274.
    PubMed     Text format     Abstract available


  158. EDELE F, Dudda JC, Bachtanian E, Jakob T, et al
    Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route.
    PLoS One. 2014;9:e105266.
    PubMed     Text format     Abstract available


  159. SLUIJTER M, van der Sluis TC, van der Velden PA, Versluis M, et al
    Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy.
    PLoS One. 2014;9:e104230.
    PubMed     Text format     Abstract available


  160. KANG S, Kim JE, Song NR, Jung SK, et al
    The Ginsenoside 20-O-beta-D-Glucopyranosyl-20(S)-Protopanaxadiol Induces Autophagy and Apoptosis in Human Melanoma via AMPK/JNK Phosphorylation.
    PLoS One. 2014;9:e104305.
    PubMed     Text format     Abstract available


  161. ASNAGHI L, Lin MH, Lim KS, Lim KJ, et al
    Hypoxia Promotes Uveal Melanoma Invasion through Enhanced Notch and MAPK Activation.
    PLoS One. 2014;9:e105372.
    PubMed     Text format     Abstract available


  162. MIGNOT G, Hervieu A, Vabres P, Dalac S, et al
    Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients.
    PLoS One. 2014;9:e105907.
    PubMed     Text format     Abstract available


  163. NOTEBAERT L, Chrystal J, Clarke PJ, Holmes EA, et al
    When we should worry more: using cognitive bias modification to drive adaptive health behaviour.
    PLoS One. 2014;9:e85092.
    PubMed     Text format     Abstract available


  164. ZHAO K, Wei L, Hui H, Dai Q, et al
    Wogonin suppresses melanoma cell b16-f10 invasion and migration by inhibiting ras-medicated pathways.
    PLoS One. 2014;9:e106458.
    PubMed     Text format     Abstract available


  165. CURL P, Vujic I, van 't Veer LJ, Ortiz-Urda S, et al
    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma.
    PLoS One. 2014;9:e107255.
    PubMed     Text format     Abstract available


  166. HARARI D, Abramovich R, Zozulya A, Smith P, et al
    Bridging the species divide: transgenic mice humanized for type-I interferon response.
    PLoS One. 2014;9:e84259.
    PubMed     Text format     Abstract available


  167. WEIDERT E, Pohler SE, Gomez EW, Dong C, et al
    Actinomyosin Contraction, Phosphorylation of VE-Cadherin, and Actin Remodeling Enable Melanoma-Induced Endothelial Cell-Cell Junction Disassembly.
    PLoS One. 2014;9:e108092.
    PubMed     Text format     Abstract available


  168. CAPASSO D, de Paola I, Liguoro A, Del Gatto A, et al
    RGDechi-hCit: alphavbeta3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells.
    PLoS One. 2014;9:e106441.
    PubMed     Text format     Abstract available


  169. BABAPOOR S, Fleming E, Wu R, Dadras SS, et al
    A Novel miR-451a isomiR, Associated with Amelanotypic Phenotype, Acts as a Tumor Suppressor in Melanoma by Retarding Cell Migration and Invasion.
    PLoS One. 2014;9:e107502.
    PubMed     Text format     Abstract available


  170. XU X, Wei WB, Li B, Gao F, et al
    Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese.
    PLoS One. 2014;9:e109699.
    PubMed     Text format     Abstract available


  171. WILLIAMS RT, Barnhill LM, Kuo HH, Lin WD, et al
    Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
    PLoS One. 2014;9:e88219.
    PubMed     Text format     Abstract available


  172. MONTURIOL-GROSS L, Flores-Diaz M, Pineda-Padilla MJ, Castro-Castro AC, et al
    Clostridium perfringens phospholipase C induced ROS production and cytotoxicity require PKC, MEK1 and NFkappaB activation.
    PLoS One. 2014;9:e86475.
    PubMed     Text format     Abstract available


  173. LINSLEY PS, Speake C, Whalen E, Chaussabel D, et al
    Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis.
    PLoS One. 2014;9:e109760.
    PubMed     Text format     Abstract available


  174. TROMME I, Devleesschauwer B, Beutels P, Richez P, et al
    Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi.
    PLoS One. 2014;9:e109339.
    PubMed     Text format     Abstract available


  175. WELINDER C, Jonsson GB, Ingvar C, Lundgren L, et al
    Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay.
    PLoS One. 2014;9:e110804.
    PubMed     Text format     Abstract available


  176. BARRIOS B, Baez NS, Reynolds D, Iribarren P, et al
    Abrogation of TNFalpha production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12.
    PLoS One. 2014;9:e90116.
    PubMed     Text format     Abstract available


  177. WU HL, Pang SL, Liu QZ, Wang Q, et al
    5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress.
    PLoS One. 2014;9:e89663.
    PubMed     Text format     Abstract available


  178. KRAMMER R, Heinzerling L
    Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls.
    PLoS One. 2014;9:e111237.
    PubMed     Text format     Abstract available


  179. DING L, Kim M, Kanchi KL, Dees ND, et al
    Clonal Architectures and Driver Mutations in Metastatic Melanomas.
    PLoS One. 2014;9:e111153.
    PubMed     Text format     Abstract available


  180. PROBST M, Hoeller C, Ferenci P, Staettermayer AF, et al
    IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma.
    PLoS One. 2014;9:e112613.
    PubMed     Text format     Abstract available


  181. MEHRA T, Grozinger G, Mann S, Guenova E, et al
    Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma.
    PLoS One. 2014;9:e112535.
    PubMed     Text format     Abstract available


  182. MOUTAI T, Yamana H, Nojima T, Kitamura D, et al
    A novel and effective cancer immunotherapy mouse model using antigen-specific B cells selected in vitro.
    PLoS One. 2014;9:e92732.
    PubMed     Text format     Abstract available


  183. SATAKE A, Schmidt AM, Nomura S, Kambayashi T, et al
    Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
    PLoS One. 2014;9:e92888.
    PubMed     Text format     Abstract available


  184. GARRISI VM, Strippoli S, De Summa S, Pinto R, et al
    Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation.
    PLoS One. 2014;9:e112025.
    PubMed     Text format     Abstract available


  185. BADE B, Zdebik A, Wagenpfeil S, Graber S, et al
    Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis.
    PLoS One. 2014;9:e112863.
    PubMed     Text format     Abstract available


  186. SHAN X, Fu Y, Aziz F, Wang X, et al
    Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation.
    PLoS One. 2014;9:e115401.
    PubMed     Text format     Abstract available


  187. ONKEN MD, Li J, Cooper JA
    Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration.
    PLoS One. 2014;9:e115472.
    PubMed     Text format     Abstract available


  188. HAGGERTY TJ, Dunn IS, Rose LB, Newton EE, et al
    Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells.
    PLoS One. 2014;9:e114506.
    PubMed     Text format     Abstract available


  189. JIANG G, Li RH, Sun C, Liu YQ, et al
    Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis.
    PLoS One. 2014;9:e111920.
    PubMed     Text format     Abstract available


  190. CARPI S, Fogli S, Giannetti A, Adinolfi B, et al
    Theranostic Properties of a Survivin-Directed Molecular Beacon in Human Melanoma Cells.
    PLoS One. 2014;9:e114588.
    PubMed     Text format     Abstract available


  191. JIANG H, Clise-Dwyer K, Ruisaard KE, Fan X, et al
    Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model.
    PLoS One. 2014;9:e97407.
    PubMed     Text format     Abstract available


  192. SINGH S, Yang G, Schluns KS, Anthony SM, et al
    Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge.
    PLoS One. 2014;9:e90001.
    PubMed     Text format     Abstract available


  193. BEHR M, Kaufmann JK, Ketzer P, Engelhardt S, et al
    Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.
    PLoS One. 2014;9:e95723.
    PubMed     Text format     Abstract available


  194. JOSHI S, Singh AR, Zulcic M, Bao L, et al
    Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo.
    PLoS One. 2014;9:e95893.
    PubMed     Text format     Abstract available


  195. LI J, Doyle MA, Saeed I, Wong SQ, et al
    Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment.
    PLoS One. 2014;9:e95217.
    PubMed     Text format     Abstract available


  196. WANG Y, Freemantle N, Nazareth I, Hunt K, et al
    Gender differences in survival and the use of primary care prior to diagnosis of three cancers: an analysis of routinely collected UK general practice data.
    PLoS One. 2014;9:e101562.
    PubMed     Text format     Abstract available


  197. MULLER JR, Waldmann TA, Dubois S
    Loss of cytotoxicity and gain of cytokine production in murine tumor-activated NK cells.
    PLoS One. 2014;9:e102793.
    PubMed     Text format     Abstract available


  198. DA SILVA PC, Rosembach TV, Santos AA, Rocha MS, et al
    Normal and tumoral melanocytes exhibit q-Gaussian random search patterns.
    PLoS One. 2014;9:e104253.
    PubMed     Text format     Abstract available


  199. CHEN SC, Su YC, Lu YT, Ko PC, et al
    Defects in the Acquisition of Tumor-Killing Capability of CD8+ Cytotoxic T Cells in Streptozotocin-Induced Diabetic Mice.
    PLoS One. 2014;9:e109961.
    PubMed     Text format     Abstract available


    January 2013
  200. XIAO J , Zhang G, Qiu P, Liu X, et al
    Tanshinone IIA Increases the Bystander Effect of Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy via Enhanced Gap Junctional Intercellular Communication.
    PLoS One. 2013;8:e67662.
    PubMed     Text format     Abstract available


  201. KING AJ, Arnone MR, Bleam MR, Moss KG, et al
    Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions.
    PLoS One. 2013;8:e67583.
    PubMed     Text format     Abstract available


  202. KOMINE H, Kuhn L, Matsushita N, Mule JJ, et al
    Examination of MARCO activity on dendritic cell phenotype and function using a gene knockout mouse.
    PLoS One. 2013;8:e67795.
    PubMed     Text format     Abstract available


  203. GOTTFRIED E, Lang SA, Renner K, Bosserhoff A, et al
    New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.
    PLoS One. 2013;8:e66987.
    PubMed     Text format     Abstract available


  204. YANG CH, Yue J, Sims M, Pfeffer LM, et al
    The curcumin analog EF24 targets NF-kappaB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
    PLoS One. 2013;8:e71130.
    PubMed     Text format     Abstract available


  205. GOTTSCHALK S, Yu F, Ji M, Kakarla S, et al
    A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.
    PLoS One. 2013;8:e82658.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Pfizer Oncology.

Design: